3416-26-0 Lidoflazine
| Nome do produto |
Lidoflazine |
| Nome em inglês |
Lidoflazine; alpha-(4-(4,4-bis(4-fluorophenyl)butyl)piperazin-1-ylacet)-2,6-xylidide; 4-[4,4-Bis(4-fluorophenyl)butyl]-N-(2,6-dimethylphenyl)-1-piperazine acetamide; 2-{4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl}-N-(2,6-dimethylphenyl)acetamide |
| Fórmula molecular |
C30H35F2N3O |
| Peso Molecular |
491.6152 |
| InChI |
InChI=1/C30H35F2N3O/c1-22-5-3-6-23(2)30(22)33-29(36)21-35-19-17-34(18-20-35)16-4-7-28(24-8-12-26(31)13-9-24)25-10-14-27(32)15-11-25/h3,5-6,8-15,28H,4,7,16-21H2,1-2H3,(H,33,36) |
| CAS Registry Number |
3416-26-0 |
| EINECS |
222-312-8 |
| Estrutura Molecular |
|
| Densidade |
1.161g/cm3 |
| Ponto de fus?o |
158-162℃ |
| Ponto de ebuli??o |
632.6°C at 760 mmHg |
| índice de refra??o |
1.581 |
| O ponto de inflama??o |
336.4°C |
| Press?o de vapor |
6.57E-16mmHg at 25°C |
| Descri??o da Seguran?a |
S24/25:Avoid contact with skin and eyes.;
|
|